A DOUBLE-BLIND COMPARISON OF FLUVOXAMINE, DESIPRAMINE AND PLACEBO IN OUTPATIENTS WITH DEPRESSION

被引：32

作者：

ROTH, D ^{[1
]}

MATTES, J ^{[1
]}

SHEEHAN, KH ^{[1
]}

SHEEHAN, DV ^{[1
]}

机构：

[1] PSYCHOPHARMACOL RES ASSOC PRINCETON, PRINCETON, NJ USA

来源：

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY | 1990年 / 14卷 / 06期

关键词：

Depression; Desipramine; Double-Blind; Fluvoxamine;

D O I：

10.1016/0278-5846(90)90078-U

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Deborah Roth, Jeffrey Mattes, K. Harnett Sheehan and David V. Sheehan: A Double-Blind Comparison of Fluvoxamine, Desipramine and Placebo in Outpatients with Depression. Prog. Neuro-Psychopharmacol. & Biol. Psychiat. 1990, 14: 929-939. 1. 1. The efficacy of fluvoxamine is compared to that of desipramine in a multicenter double blind placebo controlled six-week flexible dose trial of 90 outpatients with major depressive disorder. 2. 2. Although overall drug effects were relatively weak, there were trends suggesting separation of both active drugs from placebo at week six. Both drugs were well tolerated. 3. 3. Studies of major depression ought to be designed to last 8-10 weeks in order to demonstrate placebo active drug differences and the stability of such a difference should it occur in the first six weeks. © 1990.

引用

页码：929 / 939

页数：11

共 41 条

[1]

ASBERG M, 1976, SCIENCE, V191, P478

[2]

ASHCROFT GW, 1966, LANCET, V2, P1049

[3] AN INVENTORY FOR MEASURING DEPRESSION [J].